Dr. Govind Babu

Dr K Govind Babu is a Senior Consultant in Medical Oncology in Bangalore with 44 years of experience in the treatment of solid tumours and haemato-oncology through chemotherapy, targeted therapy, immunotherapy, and precision medicine.

He holds a DM in Medical Oncology from Kidwai Memorial Institute of Oncology, Bangalore and has completed specialty training at Dana-Farber Cancer Institute and MD Anderson Cancer Centre, USA, two of the world's foremost dedicated cancer institutions.

He has treated over 3,00,000 cancer patients across his career and served for over three decades as Professor at Kidwai Memorial Institute of Oncology, Bangalore. Patients seeking expert cancer treatment in Bangalore, trusted targeted therapy and precision medicine in Double Road, or advanced haemato-oncology in Bangalore will find Dr Govind Babu at HCG Cancer Centre, Double Road, Bangalore.

He is the President of the Indian Society of Medical and Paediatric Oncology (ISMPO), President of the SAARC Federation of Oncology, and Co-Chair of ESMO India Summit 2020, and has over 60 national and international peer-reviewed publications to his credit.

He consults in English, Hindi, Kannada, Telugu, and Tamil, ensuring clear communication for patients from across south India.

Specialty Areas and Treatments

Dr K Govind Babu delivers comprehensive medical oncology and haemato-oncology care through evidence-based, precision-guided, and patient-centred treatment approaches across solid tumours and haematological malignancies.

Treatment Modalities

• Chemotherapy intravenous, oral, HIPEC, and PIPAC protocols
• Targeted Therapy and Precision Medicine for molecularly profiled solid tumours and blood cancers
• Immunotherapy checkpoint inhibitors for eligible solid and haematological cancers
• Genomic Profiling and Personalised Treatment Planning based on tumour molecular biology
• Hormone Therapy for hormone-sensitive cancers
• HIPEC (Hyperthermic Intraperitoneal Chemotherapy) for peritoneal malignancies
• Multidisciplinary Cancer Management through tumour board-based treatment planning

Head and Neck Cancer in Bangalore

Dr Govind Babu has co-authored the Indian Clinical Practice Consensus Guidelines for the Management of Hypopharyngeal Cancer reflecting national-level expertise in head and neck oncology:

• Oral Cavity Cancer chemotherapy and targeted therapy
• Oropharyngeal and Hypopharyngeal Cancer with published national consensus guidelines
• Laryngeal Cancer organ preservation and systemic management
• Nasopharyngeal Carcinoma chemotherapy and immunotherapy
• Thyroid Cancer systemic management for advanced cases

Breast Cancer in Bangalore

• HER2 Positive Breast Cancer trastuzumab and pertuzumab-based regimens
• Triple Negative Breast Cancer chemotherapy and immunotherapy
• Hormone Receptor Positive Breast Cancer CDK 4/6 inhibitors and endocrine therapy
• Metastatic Breast Cancer targeted and systemic management
• Neoadjuvant and Adjuvant Chemotherapy for early breast cancer

Lung Cancer in Double Road

• EGFR, ALK, ROS1 Mutated NSCLC targeted therapy
• Immunotherapy for Lung Cancer PD-L1 directed agents
• Small Cell Lung Cancer chemotherapy and immunotherapy
• Advanced and Metastatic NSCLC systemic management

Gastrointestinal Cancers in Bangalore

• Colorectal Cancer FOLFOX, FOLFIRI, bevacizumab, cetuximab
• Gastric Cancer chemotherapy and targeted therapy
• Pancreatic Cancer gemcitabine-based systemic management
• Hepatocellular Carcinoma sorafenib, bevacizumab, atezolizumab combinations
• Gallbladder and Cholangiocarcinoma platinum-based regimens
• Oesophageal Cancer chemotherapy and targeted therapy

Kidney, Bladder, and Prostate Cancer in Bangalore

• Renal Cell Carcinoma targeted therapy and immunotherapy
• Bladder Cancer chemotherapy and immunotherapy
• Prostate Cancer hormone therapy, chemotherapy, and novel agents

Haemato-Oncology in Bangalore

• Leukaemia AML, ALL, CML, CLL management
• Lymphoma Hodgkin and Non-Hodgkin across all subtypes
• Multiple Myeloma proteasome inhibitors and immunomodulatory agents
• Complex Haematological Disorders systemic management

Qualifications

• MBBS from St Johns Medical College, Karnataka (1982)
• MD Internal Medicine from Bangalore Medical College and Research Institute, Bengaluru (1986)
• DM Medical Oncology from Kidwai Memorial Institute of Oncology, Bangalore (1995)
• Specialty Training in Oncology, Dana-Farber Cancer Institute, Boston, USA
• Specialty Training in Oncology, MD Anderson Cancer Centre, Houston, USA

Dr Govind Babu holds active medical council registration with the Karnataka Medical Council (Reg. No. 21290, 1982).

His subsequent over three decades as Professor at Kidwai Memorial Institute of Oncology reflect a career combining the highest levels of clinical practice, oncology education, and academic research at a leading government cancer institution.

Milestones and Clinical Achievements

• Over 3,00,000 cancer patients treated across 44 years of clinical practice
• Over 60 national and international peer-reviewed publications in oncology
• Professor at Kidwai Memorial Institute of Oncology, Bangalore for over three decades, training generations of oncologists
• Co-authored Indian Clinical Practice Consensus Guidelines for Hypopharyngeal Cancer management
• Active participation in multiple national and international clinical trials in oncology
• Active engagement with global oncology thought leadership including hosting international faculty such as Dr Richard Finn from UCLA Division of Hepatobiliary Medicine on advances in unresectable hepatocellular carcinoma management

Research and Publications

Dr K Govind Babu has 411 peer-reviewed publications with 5,725 citations on ResearchGate, making him one of the most prolific oncology researchers in south India. His research spans head and neck oncology guidelines, breast cancer, lung cancer, haematological malignancies, colorectal cancer, and precision oncology.

He has served as a named author on multiple Pan-Asian ESMO Clinical Practice Guidelines and has been a key contributor to all major Indian Clinical Practice Consensus Guidelines for Head and Neck Cancer across multiple update cycles. Selected publications include:

• Indian Clinical Practice Consensus Guidelines for the Management of Recurrent, Persistent, or Metastatic Squamous Cell Carcinoma of Head and Neck: Update 2024, Cancer Research Statistics and Treatment, October 2025
• Indian Clinical Practice Consensus Guidelines for the Management of Oropharyngeal Cancer: Update 2024, Cancer Research Statistics and Treatment, October 2025
• Indian Clinical Practice Consensus Guidelines for the Management of Locoregional Hypopharyngeal Cancer: Update 2024, Cancer Research Statistics and Treatment, October 2025
• Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Diagnosis, Treatment and Follow-Up of Patients with Endometrial Cancer, ESMO Open, January 2023
• Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Diagnosis, Treatment and Follow-Up of Patients with Metastatic Colorectal Cancer, ESMO Open, May 2023
• Consensus Guidelines for the Management of HR-Positive HER2/Neu Negative Early Breast Cancer in India, SAARC Region and Other LMIC by Delphi Survey Method, BMC Cancer, July 2023
• Pan-Asian Adapted ESMO Clinical Practice Guidelines for the Management of Patients with Locally-Advanced Unresectable Non-Small-Cell Lung Cancer, Annals of Oncology, February 2020
• Drug Susceptibility Testing of Circulating Lung Cancer Cells for Personalised Treatment, Medical Oncology, October 2022
• Circulating Tumour Cell Cluster Phenotype and Response to Treatment and Predicts Survival in Lung Cancer, International Journal of Cancer Care and Delivery, October 2022
• The Usefulness of CanAssist Breast over Ki67 in Breast Cancer Recurrence Risk Assessment, Cancer Medicine, May 2023

About HCG Cancer Centre, Bangalore

HCG Cancer Centre, Double Road, Bangalore is one of India's leading dedicated cancer treatment centres under the Healthcare Global Enterprises network.

The centre offers comprehensive cancer care including radiation oncology, robotic surgery, medical oncology, paediatric oncology, HIPEC, and preventive oncology, with state-of-the-art technology including CyberKnife, PET-CT, Versa HD, and da Vinci robotic surgical system.

HCG is India's largest cancer care network and pioneered the model of comprehensive, technology-driven, multidisciplinary cancer care in India.

Hospital Affiliations in Bangalore

Current Practice

Dr K Govind Babu currently serves as Senior Consultant, Medical Oncology at HCG Cancer Centre, Double Road, Bangalore.

Past Experience

Dr Govind Babu served as Professor of Medical Oncology at Kidwai Memorial Institute of Oncology, Bangalore from 1990 to February 2023, one of the longest and most distinguished careers at any government cancer institute in south India.

Book an Appointment with Dr K Govind Babu, Medical Oncologist in Bangalore

To check consultation fees and book a priority appointment with Dr K Govind Babu at HCG Cancer Centre, Double Road, Bangalore, visit HexaHealth for a smooth and hassle-free booking experience.